SomaLogic's Series F - II Round

SomaLogic raised a round of funding on January 04, 2018.

SomaLogic is a protein biomarker discovery and clinical diagnostics company leveraging its Slow Off-rate Modified Aptamer (SOMAmer) technology. The company aims to develop and commercialize breakthrou…

Articles about SomaLogic's Series F - II Round: